RAPP
NASDAQ · Pharmaceuticals
Rapport Therapeutics Inc
$45.49
-0.86 (-1.86%)
Open$47.00
Previous Close$46.35
Day High$48.00
Day Low$44.91
52W High$46.72
52W Low$13.62
Volume—
Avg Volume305.0K
Market Cap2.22B
P/E Ratio—
EPS$-2.60
SectorPharmaceuticals
Analyst Ratings
Strong Buy
19 analysts
Price Target
-0.7% upside
Current
$45.49
$45.49
Target
$45.18
$45.18
$32.24
$45.18 avg
$61.72
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 234.18M | 211.21M | 206.84M |
| Net Income | 54.92M | 48.45M | 43.47M |
| Profit Margin | 23.5% | 22.9% | 21.0% |
| EBITDA | 80.71M | 80.88M | 78.48M |
| Free Cash Flow | 32.46M | 39.08M | 24.42M |
| Rev Growth | +10.7% | -0.4% | +18.1% |
| Debt/Equity | 0.72 | 0.64 | 0.71 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |